Flolipid
Product Images NDC 29273-402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flolipid (NDC 29273-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salerno Pharmaceuticals Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Simvastatin 20mg.jpg (Flolipid 20mg Carton)

Simvastatin 20mg.jpg (Flolipid 20mg Carton)
FloLipid Simvastatin 20mg/5mL Oral Suspension is a medication available in a 150 mL bottle, NDC 2927340104.*
FDA Label Image

Simvastatin 20mg.jpg (Flolipid 20mg Label)

Simvastatin 20mg.jpg (Flolipid 20mg Label)
This is a description of FloLipid oral suspension, containing Simvastatin, USP. The inactive ingredients include ethylparaben, magnesium aluminum silicate, methylparaben, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium lauryl sulfate, sodium carboxymethylcellulose sodium, citric acid monohydrate, sodium citrate, diabasic and anhydrous, strawberry flavour. The product comes in a 150 mL container and should be stored at controlled room temperature, 20%-25°C (68°-77°F). The first opening date should be marked and unused portions should be discarded 30 days after. The package insert should be read before use and the drug should be kept out of reach of children.*
FDA Label Image

Simvastatin 20mg.jpg (Flolipid 40mg Carton)

FDA Label Image

Simvastatin 40mg (Flolipid 40mg Label)

Simvastatin 40mg (Flolipid 40mg Label)
Each 5mL of FloLipid oral suspension contains 40 mg of Simvastatin, USP. It is an oral medication used for treating high cholesterol and triglyceride levels. The medication is stored at controlled room temperature, preferably 20°-25°C (68°-77°F) and should not be refrigerated or frozen. It is packed in a tamper-evident container of 150 mL and should be used within 30 days after opening. It contains inactive ingredients like acesulfame potassium, carboxymethylcellulose sodium, citric acid monohydrate, ethylparaben, magnesium aluminum silicate, methylparaben, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium lauryl sulfate, sodium lactate, diabasic, and anhydrous strawberry flavor. Read the package insert before use to get detailed information about the medication. It is manufactured by Rosemont Pharmaceuticals Ltd, Leeds, LS11 9XE, UK, and is made in the United Kingdom.*
FDA Label Image

Figure 1 (Flolipid Fig1)

Figure 1 (Flolipid Fig1)
The text seems to be a part of a research paper that contains statistical information about a treatment with Simvastatin and its effects on major vascular and coronary events. It includes data on the baseline characteristics of the patients such as age, gender, diabetes, and other diseases. The text also presents the incidence rates and risk ratios of major vascular and coronary events for patients treated with Simvastatin and Placebo.*
FDA Label Image

Chemical Structure (Flolipid Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.